Living with Fabry disease? See if you qualify

Thank you for your interest in discovering more about a new clinical study that is currently enrolling men and women living with Fabry disease.

See if you qualify


The STAAR study has been designed to investigate the potential of an investigational gene therapy called ST-920 to treat men and women living with Fabry disease.

Study highlights

  • Participants will be able to continue their treatment with Enzyme Replacement Therapy (ERT) as needed
  • This study is recruiting male and female Fabry patients
  • Participants will not be required to undergo pre-conditioning chemotherapy

People who qualify will receive:

  • Study-related medical care
  • Reimbursement for travel
  • All people who pass screening assessments and enter into the study will receive the study drug ST-920